Company Cytosorbents Corp OTC Bulletin Board
Equities
US23283X2062
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Jun. 28 | Cytosorbents Corporation announced that it expects to receive $20 million in funding | CI |
Jun. 24 | CytoSorbents' Blood Purification Device Gets Approval in Taiwan | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
CytoSorb
85.3
%
| 29 | 82.4 % | 31 | 85.3 % | +8.55% |
Grant
14.5
%
| 5 | 15.4 % | 5 | 14.5 % | -1.21% |
Other
0.2
%
| 1 | 2.3 % | 0 | 0.2 % | -91.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other Countries
49.7
%
| 16 | 45.6 % | 18 | 49.7 % | +14.08% |
Germany
35.7
%
| 13 | 36.2 % | 13 | 35.7 % | +3.17% |
United States
14.7
%
| 6 | 18.2 % | 5 | 14.7 % | -15.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Chief Tech/Sci/R&D Officer | 55 | 20-04-30 | |
Steven Sisk
CTO | Chief Tech/Sci/R&D Officer | - | 15-08-17 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
James Komsa
PRN | Corporate Officer/Principal | - | 21-01-10 |
Corporate Officer/Principal | - | 13-04-14 | |
Sales & Marketing | - | 12-08-12 | |
General Counsel | 69 | 23-01-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
Alan Sobel
BRD | Director/Board Member | 63 | 14-11-12 |
Jiny Kim
BRD | Director/Board Member | 47 | 22-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,306,415 | 52,568,307 ( 96.80 %) | 0 | 96.80 % |
Company contact information
![address Cytosorbents Corp](https://cdn.zonebourse.com/static/address/18892406.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 156B | |
+31.66% | 113B | |
+1.18% | 64.26B | |
+19.45% | 54.98B | |
-3.44% | 47.44B | |
-9.28% | 36.7B | |
-0.10% | 34.84B |
- Stock Market
- Equities
- CTSO Stock
- Stock
- Company Cytosorbents Corp